Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 6/20 | 0.50 |
| ▸ | HCRTR2 | O43614 | 6/20 | 0.50 |
| ▸ | TSHR | P16473 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | ELANE | P08246 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | KDM5A | P29375 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6972771 | 0.85 | SMN1; SMN2 (0.48) | HCRTR1HCRTR2TSHRLMNASMN1; SMN2 | |
| SCHEMBL6975896 | 0.83 | HCRTR1 (0.47) | HCRTR1HCRTR2TSHRLMNASMN1; SMN2 | |
| SCHEMBL6973405 | 0.82 | HCRTR1 (0.52) | HCRTR1HCRTR2TSHRLMNASMN1; SMN2 | |
| SCHEMBL6979417 | 0.82 | KDM4E (0.50) | HCRTR1HCRTR2TSHRLMNASMN1; SMN2 | |
| SCHEMBL6975651 | 0.82 | RAB9A (0.47) | HCRTR1HCRTR2LMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL7680423 | 0.80 | LMNA (0.58) | HCRTR1HCRTR2TSHRLMNASMN1; SMN2 | |
| SCHEMBL6975687 | 0.77 | LMNA (0.43) | HCRTR1HCRTR2TSHRLMNASMN1; SMN2 | |
| SCHEMBL6975246 | 0.77 | LMNA (0.54) | TSHRLMNASMN1; SMN2MAPTHTT | |
| SCHEMBL6975277 | 0.76 | LMNA (0.48) | HCRTR1HCRTR2TSHRLMNASMN1; SMN2 | |
| SCHEMBL6968264 | 0.76 | OPRK1 (0.56) | TSHRLMNASMN1; SMN2MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1100797-B1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES | PFIZER LTD (GB) | 2003-02-26 | — | — | EP | claimed |
| US-6372736-B1 | ENZYME INHIBITORS | PFIZER INC | 2002-04-16 | — | — | US | claimed |
| US-6562964-B1 | Inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders | PFIZER INC | 2003-05-13 | — | — | US | disclosed |
| EP-1100797-B1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES | PFIZER LTD (GB) | 2003-02-26 | — | — | EP | disclosed |
| US-6372736-B1 | ENZYME INHIBITORS | PFIZER INC | 2002-04-16 | — | — | US | disclosed |
| EP-1100797-A1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES | Pfizer Limited (GB) | 2001-05-23 | — | — | EP | disclosed |
| WO-2000005232-A1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES | PFIZER LIMITED (GB) | 2000-02-03 | — | — | WO | disclosed |